Find the latest episode of "The Uncertain Hour" here. Listen

Novartis’ emotional pitch for Prevacid

Joel Rose Nov 12, 2009
HTML EMBED:
COPY

Novartis’ emotional pitch for Prevacid

Joel Rose Nov 12, 2009
HTML EMBED:
COPY

TEXT OF STORY

Stacey Vanek-Smith: Today Novartis launches a campaign for a new version of its heartburn drug Prevacid. It’s a crowded field. And Novartis is counting on an emotional pitch, as Joel Rose reports.


Joel Rose: Novartis is betting $200 million it can make heartburn sufferers feel warm and fuzzy about Prevacid.

TV ad: That’s when I’d had it with frequent heartburn. That’s when I got Prevacid 24-hour. And husband #2!

The ad campaign comes just as Prevacid goes on sale over the counter for the first time — and at a higher price than most of its competitors. Novartis is hoping to make up in the mass market, what it may lose in the prescription drug market, as generic competitors move in.

David Grande is a health policy researcher at the University of Pennsylvania.

David Grande: They probably are banking on the fact they can make that they’re going to be able to make emotional appeal, and make that connection to consumers, and generate a level of business they wouldn’t be able to generate on the prescription market.

That’s because insurance companies often push consumers to cheaper generics. When it comes to the over-the-counter market, consumers make their own decisions.

I’m Joel Rose for Marketplace.

Marketplace is on a mission.

We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.

Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?

Your donation is critical to the future of public service journalism. Support our work today – for as little as $5 – and help us keep making people smarter.